Daxin Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
- Paid Up Capital ₹ 9.84 Cr
- Company Age 11 Year, 2 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 20.61 Cr
- Satisfied Charges ₹ 1.95 Cr
- Revenue Growth 128.97%
- Profit Growth -84.12%
- Ebitda 21.02%
- Net Worth 267.21%
- Total Assets 20.65%
About Daxin Pharmaceuticals
Daxin Pharmaceuticals Private Limited (DPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 06 February 2014 and has a history of 11 years. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 9.84 Cr.
The company currently has active open charges totaling ₹20.61 Cr. The company has closed loans amounting to ₹1.95 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sheela Jha and Nikhil Jha serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24100DL2014PTC264559
-
Company No.
264559
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
06 Feb 2014
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Daxin Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sheela Jha
|
Director | 06-Feb-2014 | Current |
|
Nikhil Jha
|
Director | 16-Feb-2014 | Current |
Financial Performance of Daxin Pharmaceuticals.
Daxin Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 128.97% increase. The company also saw a substantial fall in profitability, with a 84.12% decrease in profit. The company's net worth Soared by an impressive increase of 267.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Daxin Pharmaceuticals?
In 2023, Daxin Pharmaceuticals had a promoter holding of 60.51% and a public holding of 39.49%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Daximed Healthcare Private LimitedSheela Jha and Nikhil Jha are mutual person
Charges (Loans)
₹20.61 Cr
₹1.95 Cr
Charges Breakdown by Lending Institutions
- Others : 20.61 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Apr 2024 | Others | ₹3.30 M | Open |
| 25 Nov 2021 | Others | ₹1.05 Cr | Open |
| 20 Nov 2020 | Others | ₹19.23 Cr | Open |
| 30 May 2015 | Others | ₹1.95 Cr | Satisfied |
How Many Employees Work at Daxin Pharmaceuticals?
Daxin Pharmaceuticals has a workforce of 137 employees as of Sep 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Daxin Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Daxin Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
